ICHRAs, a Growth Opportunity for Insurers, Face Uphill Battle

Why It Matters

ICHRAs could become a vital growth engine for insurers as fully insured enrollment declines, but success depends on market stability and the ability to deliver digital, consumer‑focused solutions.

Key Takeaways

• ICHRA adoption rose 19% from 2024 to 2025, 34% among large employers.
• Fully insured enrollment fell to 38M (large) and 10M (small) by 2023.
• Insurers such as Centene and Oscar are promoting ICHRAs to small groups.
• ACA market volatility and regulatory uncertainty threaten ICHRA growth.
• Success requires digital tools, education, and integration with existing payer strategies.

Pulse Analysis

The rise of Individual Coverage Health Reimbursement Arrangements marks a fundamental shift from traditional group health plans to a defined‑contribution model. By reimbursing employees for marketplace policies, ICHRAs give employers a fixed cost ceiling while potentially tapping lower individual premiums, especially for small‑group firms. This structure aligns with broader trends toward cost predictability and employee choice, positioning ICHRAs as a strategic lever for insurers facing a 20% drop in large‑group fully insured enrollment over the past decade.

Insurers are already testing the waters. Companies such as Centene and Oscar have launched dedicated ICHRA offerings, leveraging existing brand equity to attract employers seeking alternatives to self‑funded or fully insured plans. However, the upside is tempered by practical hurdles: the ACA marketplace’s fluctuating subsidies, state‑level rate spikes, and the lack of standardized enrollment data complicate risk assessment. To win, payers must invest in digital enrollment platforms, decision‑support tools, and robust education programs that demystify HSA integration and subsidy use. Those that embed ICHRA services within their broader employer relationships can deepen loyalty and cross‑sell ancillary products.

Looking ahead, regulatory clarity will be decisive. While the HRA Council pushes for congressional codification, legislative inertia leaves ICHRAs vulnerable to policy swings. Insurers that treat ICHRAs as an extension of their existing portfolio—rather than a standalone venture—can mitigate risk and align the product with value‑based care initiatives, such as directing members to in‑network clinics with zero copays. If they navigate the operational and policy challenges, ICHRAs could become a cornerstone of a more flexible, consumer‑centric health insurance landscape.